How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/acute-treatment-of-migraine-attacks-with-or-without-aura-in-adults.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Acute treatment of migraine attacks with or without aura in adults — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute treatment of migraine attacks with or without aura in adults (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Acute treatment of migraine attacks with or without aura in adults, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target
Rimegepant 75mg Orally Disintegrating Tablets (ODT)	rimegepant-75mg-orally-disintegrating-tablets-odt	Pfizer	calcitonin gene-related peptide receptor antagonist	calcitonin gene-related peptide receptor
Rimegepant 75mg every other day dosing	rimegepant-75mg-every-other-day-dosing	Pfizer	calcitonin gene-related peptide receptor antagonist	calcitonin gene-related peptide receptor
Rimegepant 75mg daily dosing	rimegepant-75mg-daily-dosing	Pfizer	calcitonin gene-related peptide receptor antagonist	calcitonin gene-related peptide receptor
Triptans	triptans	Pfizer	Selective serotonin receptor agonists	Serotonin 5-HT1B/1D receptors

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 4 drugs in Acute treatment of migraine attacks with or without aura in adults

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Acute treatment of migraine attacks with or without aura in adults:

Cite this brief

Drug Landscape (2026). Acute treatment of migraine attacks with or without aura in adults — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/acute-treatment-of-migraine-attacks-with-or-without-aura-in-adults. Accessed 2026-06-10.

Acute treatment of migraine attacks with or without aura in adults full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing